Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Trial of SGN-CD33A in Patients With CD33-positive Acute Myeloid Leukemia

NCT01902329 is registered in ClinicalTrials.gov with Seagen Inc. as lead sponsor.

NCT NCT01902329
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01902329 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Trial of SGN-CD33A in Patients With CD33-positive Acute Myeloid Leukemia
Lead sponsor
Seagen Inc.
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2013
Completion date
December 8, 2017
Enrollment
195 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute myelogenous leukemia, acute myeloid leukemia, acute promyelocytic leukemia